MIPS - Quality Measures -

Category	QUALITY
Description	Percentage of adult patients (aged 18 or over) with metastatic colorectal cancer and KRAS gene mutation spared treatment with anti-EGFR monoclonal antibodies
eMeasure ID
First Performance Year	2017
Last Performance Year
Metric Type	Single Performance Rate
National Quality Strategy Domain	PS
Measure Type	Process
eMeasure UUID
NQF eMeasure ID
NQF ID	1860
Is High Priority?
Is Inverse?
Overall Algorithm
Primary Steward	American Society of Clinical Oncology
Submission Methods	Registry
Eligibility Options
Performance Options
Is Risk Adjusted?
Vendor ID
Is Registry Measure?
Registry Measure Spec	https://qpp.cms.gov/docs/QPP_quality_measure_specifications/Claims-Registry-Measures/2017_Measure_452_Registry.pdf
Web Interface Measure Spec
Claims Measure Spec